Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

The impacts of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on cancer care are multiple, entailing a high risk of death from coronavirus disease 2019 (COVID-19) in patients with cancer treated by chemotherapy. SARS-CoV-2 vaccines represent an opportunity to decrease the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tougeron, David, Hentzien, Maxime, Seitz-Polski, Barbara, Bani-Sadr, Firouze, Bourhis, Jean, Ducreux, Michel, Gaujoux, Sébastien, Gorphe, Philippe, Guiu, Boris, Hoang-Xuan, Khê, Huguet, Florence, Lecomte, Thierry, Lièvre, Astrid, Louvet, Christophe, Maggiori, Léon, Mansi, Laura, Mariani, Pascale, Michel, Pierre, Servettaz, Amélie, Thariat, Juliette, Westeel, Virgine, Aparicio, Thomas, Blay, Jean-Yves, Bouché, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Current Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015403/
https://www.ncbi.nlm.nih.gov/pubmed/33934060
http://dx.doi.org/10.1016/j.ejca.2021.03.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015403/
https://www.ncbi.nlm.nih.gov/pubmed/33934060
http://dx.doi.org/10.1016/j.ejca.2021.03.030

Ejemplares similares